This Study aims to assess the impact of certain clinical factors on children with leukemia by employing The Joint Model for Longitudinal and survival data, using the Expectation–Maximization (EM) algorithm for parameter estimation. In this research, the longitudinal data are represented by repeated measurements of hemoglobin (Hb) levels over time, while the survival data correspond to the follow-up time until the realization of the event (death or censoring). The results revealed that Hb levels significantly decrease over time (p < 0.0001). Female patients had lower Hb levels compared to males (p=0.006), while older age was associated with slightly higher Hb values (p=0.0002). In the survival sub-model, the effects of age and sex were statistically insignificant (p > 0.05). Importantly, the negative and significant association parameter (γ, p=0.0001) indicated that higher Hb levels reduce the risk of death, highlighting the predictive value of longitudinal information in explaining survival outcomes. Based on the goodness-of-fit criteria (AIC and RMSE), the EM algorithm demonstrated high efficiency in estimating the parameters of the joint model and achieving strong agreement between predicted and observed values. Therefore, the joint model provides a powerful and effective tool for integrating longitudinal and survival information in the study of childhood leukemia, enhancing estimation accuracy and enabling more reliable conclusions about the factors influencing disease progression.
Keywords
Joint ModelLongitudinal and Survival DataModel Evaluation (AICRMSE)EM Algorithm.
References
M.-H. Chen, J. G. Ibrahim, and D. Sinha, “A new joint model for longitudinal and survival data with a cure fraction,” Journal of Multivariate Analysis, vol. 91, no. 1, pp. 18-34, 2004.
D. Ibrahim, L. Chu, and M.-H. Chen, “Basic concepts and methods for joint models of longitudinal and survival data,” Journal of Clinical Oncology, vol. 28, no. 16, pp. 2796-2801, 2010.
N. Al-Huniti, “Dynamic predictions of survival in non-small cell lung cancer using joint modeling,” American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting, 2018.
L. Wu, Y. Liu, G. Yi, and X. Huang, “Analysis of longitudinal and survival data: Joint modeling, inference methods, and issues,” Journal of Probability and Statistics, vol. 2012, Article ID 640153, 2012.
J. Murray and P. Philipson, “A fast approximate EM algorithm for joint models of survival and multivariate longitudinal data,” Computational Statistics & Data Analysis, vol. 170, 107437, 2022.
M. J. Crowther, K. R. Abrams, and P. C. Lambert, “Joint modeling of longitudinal and survival data,” Stata Journal, vol. 13, no. 1, pp. 165-184, 2013.
G. Babykina and G. Marot, “Longitudinal data analysis in high dimension,” M2 Internship Report, University of Lille, 2022.
V. Medina-Olivares, F. Lindgren, R. Calabrese, and J. Crook, “Joint model for longitudinal and spatio-temporal survival data,” European Journal of Operational Research, vol. 327, no. 3, pp. 892-904, 2025.
D. Rizopoulos, Notes on Joint Models for Longitudinal and Survival Data, Erasmus Medical Center, 2021.
M. S. Shahrokhabadi, D.-G. Chen, S. J. Mirkamali, A. Kazemnejad, and F. Zayeri, “Marginalized two-part joint modeling of longitudinal semi-continuous responses and survival data with application to medical costs,” Mathematics, vol. 9, no. 20, pp. 2603-2622, 2021.
T. H. Nguyen, E. Babykina, and G. Marot, “High-dimensional multivariate longitudinal data for survival analysis of cardiovascular event prediction,” BMC Medical Research Methodology, vol. 22, 2022.
V. T. Nguyen, Integrating Longitudinal Data for Enhanced Survival Analysis: Methods and Applications, PhD Thesis, Université Paris Cité, Paris, France, 2024.
M. Alkhathami, Joint Modeling of Longitudinal and Survival Data, PhD Thesis, Carleton University, Ottawa, Canada, 2021.
·
This work is licensed under a
Creative Commons Attribution-ShareAlike 4.0 International License
